Technical Analysis for INMB - INmune Bio Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.56 | -3.18% | -0.15 |
INMB closed down 3.18 percent on Wednesday, November 20, 2024, on 67 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 3% | about 21 hours ago |
| Fell Below Lower Bollinger Band | about 21 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
| Down 2 % | about 21 hours ago |
| Down 1% | about 21 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/30/2024
INmune Bio, Inc. is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer. INmune Bio is developing two products platforms that reengineer the patient’s innate immune system’s response to their cancer, INKmune and INB03. INKmune is a Natural Killer (NK) cell therapeutic that primes the patient’s NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio’s product platforms target residual disease and utilize a precision medicine approach for treatment of a wide variety of hematologic malignancies and solid tumors.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Disease Solid Tumors Immune System Immunotherapy Cancer Treatment Precision Medicine Hematologic Malignancies Checkpoint Inhibitor Tumors Of The Hematopoietic And Lymphoid Tissues Residual Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Disease Solid Tumors Immune System Immunotherapy Cancer Treatment Precision Medicine Hematologic Malignancies Checkpoint Inhibitor Tumors Of The Hematopoietic And Lymphoid Tissues Residual Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.74 |
| 52 Week Low | 4.45 |
| Average Volume | 282,334 |
| 200-Day Moving Average | 8.60 |
| 50-Day Moving Average | 5.43 |
| 20-Day Moving Average | 5.71 |
| 10-Day Moving Average | 5.44 |
| Average True Range | 0.36 |
| RSI (14) | 31.97 |
| ADX | 23.42 |
| +DI | 17.40 |
| -DI | 34.74 |
| Chandelier Exit (Long, 3 ATRs) | 5.58 |
| Chandelier Exit (Short, 3 ATRs) | 5.53 |
| Upper Bollinger Bands | 6.84 |
| Lower Bollinger Band | 4.58 |
| Percent B (%b) | -0.01 |
| BandWidth | 39.60 |
| MACD Line | -0.19 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.176 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.94 | ||||
| Resistance 3 (R3) | 4.94 | 4.82 | 4.87 | ||
| Resistance 2 (R2) | 4.82 | 4.72 | 4.82 | 4.85 | |
| Resistance 1 (R1) | 4.69 | 4.67 | 4.63 | 4.69 | 4.83 |
| Pivot Point | 4.57 | 4.57 | 4.54 | 4.57 | 4.57 |
| Support 1 (S1) | 4.44 | 4.47 | 4.38 | 4.44 | 4.29 |
| Support 2 (S2) | 4.32 | 4.42 | 4.32 | 4.27 | |
| Support 3 (S3) | 4.19 | 4.32 | 4.25 | ||
| Support 4 (S4) | 4.19 |
